Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.1100 (-8.26%) ($5.8600 - $6.5000) on Wed. Jul. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 32.46% (three month average) | RSI | 66 | Latest Price | $6.1100(-8.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 5.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 15.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BNDX(31%) BND(26%) IPO(18%) MCHI(12%) VCIT(12%) | Factors Impacting CAPR price | CAPR will decline at least -16.23% in a week (0% probabilities). XLU(-11%) UUP(-9%) UNG(-9%) GLD(-9%) EWJ(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -16.23% (StdDev 32.46%) | Hourly BBV | 0 () | Intraday Trend | -5.9% | | | |
|
5 Day Moving Average | $5.8(5.34%) | 10 Day Moving Average | $5.13(19.1%) | 20 Day Moving Average | $4.9(24.69%) | To recent high | -28.1% | To recent low | 22% | Market Cap | $120m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |